Edition:
International

Michael Erman

Explainer: What is the science behind the new U.S. mask guidance?

May 14 2021

NEW YORK The U.S. Centers for Disease Control and Prevention (CDC) on Thursday advised that fully vaccinated people do not need to wear masks outdoors and can avoid wearing them indoors in most places, updated guidance the agency said will allow life to begin to return to normal.

CDC panel clears way to COVID-19 vaccines for U.S. adolescents

May 13 2021

(Reuters) -U.S. states are set to begin using the vaccine from Pfizer Inc and BioNTech SE to inoculate young adolescents against COVID-19 after advisers to the U.S. Centers for Disease Control and Prevention (CDC) backed the plan in a unanimous vote on Wednesday. | Video

U.S. CDC finds more clotting cases after J&J vaccine, sees causal link

May 12 2021

CHICAGO (Reuters) -The U.S. Centers for Disease Control and Prevention said on Wednesday it had found more cases of potentially life-threatening blood clotting among people who received the Johnson & Johnson COVID-19 vaccine and sees a "plausible causal association."

Explainer: Should my teen get the COVID-19 vaccine?

May 12 2021

NEW YORK The U.S. Food and Drug Administration has authorized Pfizer and BioNTech’s COVID-19 vaccine for use in children as young as 12, widening the country’s inoculation program as vaccination rates have slowed significantly.

U.S. children ages 12 to 15 could begin COVID-19 vaccinations Thursday

May 11 2021

(Reuters) -U.S. regulators authorized Pfizer and BioNTech's COVID-19 vaccine for use in children as young as 12 and said they could begin receiving shots as soon as Thursday, widening the country's inoculation program as vaccination rates have slowed significantly. | Video

Free booze, baseball tickets offered as U.S. demand for COVID-19 vaccine drops

May 05 2021

Robert Day walked up to a house in northwest Detroit, eager to talk about nearby COVID-19 vaccination sites and pitch a local program that pays $50 to anyone who brings someone to a clinic to get inoculated.

Pfizer sees robust COVID-19 vaccine demand for years, $26 billion in 2021 sales

May 04 2021

(Reuters) -Pfizer Inc on Tuesday raised its forecast for 2021 COVID-19 vaccine sales by more than 70% to $26 billion and said demand from governments around the world fighting to halt the pandemic could contribute to its growth for years to come. | Video

Emergent hopes to answer U.S. FDA on Baltimore plant within days

Apr 29 2021

Contract drugmaker Emergent BioSolutions Inc said on Thursday it hopes to respond to U.S. regulators within days on how to resolve the problems at its Baltimore plant, which have forced Johnson & Johnson to largely halt U.S. manufacturing of their COVID-19 vaccine.

World News

Ceasefire still elusive in Israel-Gaza conflict

Israel bombarded Gaza with air strikes and Palestinian militants kept up cross-border rocket fire, with no firm sign on Wednesday of any imminent ceasefire despite international calls to end more than a week of fighting.